Santarus Inc Drug Patent Portfolio
Santarus Inc owns 1 orange book drug protected by 6 US patents Given below is the list of Santarus Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7780987 | Controlled release dosage forms | 23 Mar, 2025 | Active |
| US8323692 | Controlled release dosage forms | 23 Mar, 2025 | Active |
| US6723340 | Optimal polymer mixtures for gastric retentive tablets | 25 Oct, 2021 | Expired |
| US6488962 | Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms | 20 Jun, 2020 | Expired |
| US6340475 | Extending the duration of drug release within the stomach during the fed mode | 19 Sep, 2016 | Expired |
| US6635280 | Extending the duration of drug release within the stomach during the fed mode | 19 Sep, 2016 | Expired |
Latest Legal Activities on Santarus Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Santarus Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 26 Jan, 2022 | US7780987 (Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 04 Jun, 2020 | US8323692 |
| Review Certificate Mailed | 26 Jul, 2018 | US6723340 (Litigated) |
| Review Certificate | 09 Jul, 2018 | US6723340 (Litigated) |
| Review Certificate Mailed | 09 Feb, 2018 | US6635280 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 02 Feb, 2018 | US7780987 (Litigated) |
| Review Certificate | 14 Dec, 2017 | US6635280 |
| File Marked Found | 25 Apr, 2016 | US6723340 (Litigated) |
| File Marked Found | 18 Feb, 2016 | US6723340 (Litigated) |
| File Marked Found | 12 Feb, 2016 | US6723340 (Litigated) |
| Termination or Final Written Decision | 21 Sep, 2015 | US6635280 |
| Termination or Final Written Decision | 16 Sep, 2015 | US6723340 (Litigated) |
| Termination or Final Written Decision | 08 Jul, 2015 | US6635280 |
|
Request for Trial Granted
Critical
| 29 Sep, 2014 | US6635280 |
|
Request for Trial Denied
Critical
| 29 Sep, 2014 | US6635280 |
Santarus Inc's Drug Patent Litigations
Santarus Inc's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Apr 17, 2014, against patent number US6723340. The petitioner Endo Pharmaceutical Inc. et al., challenged the validity of this patent, with DepoMed, Inc. as the respondent. Click below to track the latest information on how companies are challenging Santarus Inc's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US6340475 | April, 2014 |
Final Written Decision
(21 Sep, 2015)
| Depomed, Inc. | Endo Pharmaceutical Inc. et al. |
| US6635280 | April, 2014 |
Final Written Decision
(21 Sep, 2015)
| Depomed, Inc. | Endo Pharmaceutical Inc. et al. |
| US6723340 | April, 2014 |
Final Written Decision
(16 Sep, 2015)
| DepoMed, Inc. | Endo Pharmaceutical Inc. et al. |
| US6340475 | January, 2014 |
FWD Entered
(08 Jul, 2015)
| Depomed, Inc. | Purdue Pharma L.P. |
| US6635280 | January, 2014 |
FWD Entered
(08 Jul, 2015)
| DepoMed, Inc. | Purdue Pharma L.P. |
| US6340475 | April, 2014 |
Institution Denied
(29 Sep, 2014)
| Depomed, Inc. | Endo Pharmaceutical Inc. et al. |
| US6635280 | April, 2014 |
Institution Denied
(29 Sep, 2014)
| Depomed, Inc. | Endo Pharmaceutical Inc. et al. |
| US6723340 | April, 2014 |
Institution Denied
(29 Sep, 2014)
| DepoMed, Inc. | Endo Pharmaceutical Inc. et al. |
Santarus Inc's Family Patents
Santarus Inc Drug List
Given below is the complete list of Santarus Inc's drugs and the patents protecting them.
1. Glumetza
Glumetza is protected by 6 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7780987 | Controlled release dosage forms |
23 Mar, 2025
(5 months from now)
| Active |
| US8323692 | Controlled release dosage forms |
23 Mar, 2025
(5 months from now)
| Active |
| US6723340 | Optimal polymer mixtures for gastric retentive tablets |
25 Oct, 2021
(2 years ago)
| Expired |
| US6488962 | Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms |
20 Jun, 2020
(4 years ago)
| Expired |
| US6340475 | Extending the duration of drug release within the stomach during the fed mode |
19 Sep, 2016
(8 years ago)
| Expired |
| US6635280 | Extending the duration of drug release within the stomach during the fed mode |
19 Sep, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Glumetza's drug page